Skip to content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Agenda

Note: unless specified, all meeting venues will take place in the Franklin Building

Sunday, February 24

3:00 pm - 5:30 pm
Registration and Refreshments

5:30 pm - 7:00 pm
Welcome, Dr. Paul Sieving, NEI Director
Dr. Francis Collins, NIH Director
Leonor Beleza, President of the Champalimaud Foundation
NEI Challenge Winner Recognition
Charge to Participants

7:00 pm
Dinner

**Monday, February 25

8:00 am - 9:15 am
Challenge Winner Presentations

9:15 am - 9:30 am
Break

9:30 am - 11:45 am
**AG Topic Discussion: Session 1

11:45 am - 1:00 pm
Lunch

1:00 pm - 3:00 pm
**AG Topic Discussion: Session 2

3:00 pm - 3:30 pm
Break

3:30 pm - 5:30 pm
**AG Topic Discussion: Session 3

5:30 pm - 6:00 pm
Day 1 Concluding Remarks

6:00 pm - 7:30 pm
Dinner

7:30 pm
Informal Discussions

Tuesday, February 26

7:45 am - 9:15 am
Consolidation of Presentations: Session 4

9:15 am - 9:30 am
Break

9:30 am - noon
** AG Topic Plenary Presentations and Discussion

12:00 pm - 1:00 pm
Lunch

1:00 pm - 3:00 pm
AG Topic Plenary Presentations and Discussion (continued)

3:00 pm - 3:30 pm
Final Assessment and Concluding Remarks

** Monday will consist of three sequential, 2-hr discussion sessions. Each of the following topics will be discussed in separate break-out rooms during all three sessions. This will permit meeting participants to consider and contribute to several topics over the course of the day.

A. Aging and mechanisms of disease development and progression, from molecules to cells to people.

B. Molecular therapy at the gene level

C. Systems approaches to disease analysis

D. Molecular and functional analysis and imaging of ocular tissues in vitro and in vivo

E. Regenerative therapies for ocular disease

F. Vision restoration by optogenetics, small molecules, and prosthetics

Last updated: December 31, 2024